Moeda Consulting Corp.
Scientific and strategic leadership for early-stage biotech, from proof-of-concept to IND-enabling.
Get in touchWhat We Do
Scientific, translational, and commercial due diligence of assets and IP, including spinout positioning, clinical path framing, and investor readiness. Determines whether there is a real product and whether it is worth building.
Design and execution of go/no-go strategies, including in vitro and in vivo validation, PK/PD planning, and data packages aligned with IND-enabling expectations. Evidence that supports confident decision-making.
Fractional scientific leadership across preclinical strategy, CMC and manufacturability considerations, and investor-facing data package development for fundraising milestones.
About
Moe Wehbe is a pharmaceutical scientist and drug delivery platform builder with more than a decade of experience developing and translating therapeutic delivery technologies. He earned his Ph.D. in Pharmaceutical Sciences from the University of British Columbia, where his doctoral research focused on lipid-based drug delivery and led to the co-invention of a metal-complexed liposomal technology.
He completed postdoctoral training at Vanderbilt University focused on polymeric drug delivery and immuno-engineering.
Moe later joined ReCode Therapeutics, where he worked on LNP formulation, scale-up, and translational development supporting rodent and NHP programs, as well as technology transfer to external manufacturing partners. He then became a founding scientist at Mirai Bio within the Flagship Pioneering ecosystem, helping build and optimize extrahepatic delivery systems for in vivo cell engineering and tissue-selective genetic medicines.
Moe founded Moeda Consulting Corp. to bring that combination of scientific depth, platform-building experience, and translational judgment to biotechnology companies, founders, investors, and academic teams.
What clients say
No slides required. 30 minutes. Brief on the program or question, and we will tell you if there is a fit.